




Mochi Health is one of the largest GLP-1 telehealth platforms with 100,000+ patients, 15,000+ Trustpilot reviews (4.4/5), and board-certified providers conducting live video visits. Their $99/month flat-rate compounded semaglutide at all doses is among the most competitive available, and insurance integration for brand-name GLP-1s adds real flexibility. However, significant regulatory concerns loom — an active Eli Lilly lawsuit over compounded tirzepatide marketing, a 2025 pharmacy partner shutdown for unsafe compounding practices, and questions about CEO credentials raised in court filings. Strong clinical model, but patients should weigh ongoing legal and operational risks carefully.
Board-certified obesity medicine physicians and dietitians conduct real video consultations — not just questionnaire-based prescribing. Flat pricing ($99/mo semaglutide, $199/mo tirzepatide at all doses) eliminates titration price hikes. Wellness Plus plan bundles behavioral therapy, nutrition counseling, and health screenings with a $0 surprise-bill guarantee for insured patients. Mochi also now offers pediatric weight management, GLP-1 microdosing, and reports an average 36 pounds lost in the first year.
Billing and cancellation complaints are very common — $79 membership is non-refundable after 24 hours, multi-month plans can't be prorated, and patients report charges after cancellation. Mochi's primary pharmacy partner Aequita was shut down by Washington State in March 2025 for sterile compounding violations, causing widespread patient disruption. Eli Lilly's lawsuit alleges Mochi changed patient doses en masse at least five times in eight months without consultation. Multiple customers report medications arriving warm without proper temperature control.
Mochi offers one of the most clinically comprehensive and price-competitive telehealth weight loss programs available, especially for insured patients using Wellness Plus. However, the active Eli Lilly lawsuit (initial complaint dismissed Oct 2025, amended complaint still pending), Aequita pharmacy shutdown, and persistent billing issues mean going in with eyes open is essential. Strong care model with real regulatory baggage — read cancellation policies carefully before signing up.
Membership is $79/month (Health + Medication Plan) or $69/month with qualifying insurance (Wellness Plus). Limited-time offer: 50% off the first month ($39). Compounded semaglutide is $99/month and compounded tirzepatide is $199/month at all doses, with discounts on 3-month and 12-month commitments. Brand-name medications are billed separately through insurance. HSA/FSA accepted.
Yes, for brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Trulicity) with prior authorization support. Wellness Plus members with qualifying insurance get $0 copays on services like therapy, nutrition, and screenings — with a guarantee Mochi covers denied claims. Membership fees are always out of pocket; compounded medications are cash-pay only. Medicaid, Medicare, and TRICARE are not accepted.
Brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Victoza, Trulicity) through insurance, plus compounded semaglutide and tirzepatide at flat monthly rates. GLP-1 microdosing is also available. Non-GLP-1 options include topiramate, bupropion, and orlistat. Phentermine is not offered. All prescriptions require a video consultation.
Yes, Mochi Health is LegitScript certified and available in all 50 U.S. states and Washington, D.C. They also offer a pediatric program for patients under 18. All consultations are conducted via live video with board-certified providers.
All plans include 24/7 support, provider messaging, video visits with physicians and dietitians, medication management, and a patient portal/mobile app. Wellness Plus (with insurance) adds advanced nutrition therapy, custom diet planning, behavioral therapy, health screenings, and more at $0 additional cost. Optional add-ons include lab work, genetic testing, and sleep apnea assessments.